Northern Jiangsu People's Hospital

This study is testing whether combining an immunotherapy drug (tislelizumab) with targeted radiation before surgery can help shrink or eliminate tumors in people with operable non-small cell lung cancer. The goal is to see if this pre-surgery treatment makes the cancer easier to …

This study is testing whether delivering a specific chemotherapy regimen directly into the liver's artery after surgery can help prevent liver cancer from coming back in patients at high risk of recurrence. It will enroll about 30 adults who have recently had successful surgery t…

This study is testing if the medication apixaban (a blood thinner) is safe and effective for treating and preventing blood clots in the main vein of the liver (portal vein thrombosis) in people with liver cirrhosis. It focuses on patients who had their spleen removed over a year …

This study is testing whether adding a capsule called Icaritin to a specific type of chemotherapy can help prevent liver cancer from returning after surgery. It is for patients whose cancer has a high risk of coming back. Researchers will check if this combination is safe and eff…

This study is comparing two types of minimally invasive spleen surgery for people with advanced liver disease. Researchers want to see if removing only part of the spleen, instead of the whole organ, helps patients' immune systems recover better after surgery. They will measure b…

This study is testing whether adding a second steroid (fludrocortisone) to the standard steroid (hydrocortisone) helps adults with life-threatening septic shock. It will compare the two-drug combination against standard care in 336 patients. The main goal is to see if the combina…

This study aims to understand why some people with diabetes develop gastroparesis, a condition where the stomach muscles don't work properly, causing nausea and bloating. Researchers will compare blood and stomach tissue samples from 50 people with diabetic gastroparesis to sampl…